HCT-116-luc Orthotopic Model

Synonyms:

HCT-116-luc is a luminescent colon cancer cell line derived from HCT-116. It expresses luciferase, allowing for non-invasive monitoring of tumor growth and response to therapies using bioluminescence imaging techniques. HCT-116-luc serves as a valuable tool for studying colon cancer, evaluating drug efficacy, and investigating therapeutic approaches. Researchers utilize this cell line to explore colon cancer biology, identify novel targets, and test anti-cancer agents in preclinical studies.

Model Details

Cancer Type: -B-
Model Name: HCT-116-luc
Mouse Strain: CB.17 SCID
Treatment Data Available: N/A

HCT-116-luc Growth curves

HCT-116-luc Orthotopic Model

Growth of HCT-116-luc after IP disseminated injection of CB.17 SCID mice (n=5)

Request Additional Syngeneic Model Data

CONTACT US

Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our expert staff today to get started.